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Suppression of the cytotoxic T cell (CTL) immune
response has been proposed as one mechanism
for immune evasion in cancer. In this study, we
have explored the underlying basis for CTL suppres-
sion in the context of B cell malignancies. We docu-
ment that human B cells have an intrinsic ability to
resist killing by freshly isolated cytotoxic T cells
(CTLs), but are susceptible to lysis by IL-2 activated
CTL blasts and CTLs isolated from immunotherapy-
treated patients with chronic lymphocytic leukemia
(CLL). Impaired killing was associated with the for-
mation of dysfunctional non-lytic immune synapses
characterized by the presence of defective linker
for activation of T cells (LAT) signaling and non-polar-
ized release of the lytic granules transported by ADP-
ribosylation factor-like protein 8 (Arl8). We propose
that non-lytic degranulation of CTLs are a key regula-
tory mechanism of evasion through which B cells
may interfere with the formation of functional im-
mune synapses by CTLs.
INTRODUCTION
A global dysfunction of cytotoxic T cells (CTLs) has been
observed in many types of tumors and persisting infections
that have been generally associated with a so-called ‘‘immune
exhaustion.’’ Dysfunction involves an up-regulation of inhibitory
receptors, reduced cytokine production, and impaired activity
of CTLs (Speiser et al., 2014). Nevertheless, a strong rationale
behind therapeutic approaches aiming to reactivate latent
CTLs comes from studies in which anti-tumor immunity can be
restored in melanoma patients by blocking the inhibitory check-
point receptors (Pardoll, 2012). Thus, a better understanding of
the exhaustionmechanisms could further contribute to the spec-
trum of therapies aimed at reversing functional anergy of CTLs in
various pathological settings.This is an open access article under the CC BY-NCTL cytotoxicity depends on the recognition of cognate tar-
gets by the antigen-specific T cell receptor (TCR) followed by a
directed release of the contents of specialized secretory lyso-
somes called ‘lytic granules’ toward the target. This degranula-
tion process depends on the formation of the lytic immune syn-
apse (IS) between the effector CTL and the target resulting in the
translocation of the CTL’s microtubule organizing center (MTOC)
towards the synaptic interface. MTOC docking beneath the IS
that depends on protein kinase C (PKC) isoforms (Liu et al.,
2013) ensures dynein- and Ca2+-dependent targeted delivery
and exocytosis of the granule content directly into the synaptic
cleft, which results in target cell lysis by concerted action of gran-
zymes and perforin (Stinchcombe et al., 2006).
Notmuch is known about regulation of lytic granule exocytosis
in CTLs, especially with respect to their dysfunction in tumor
pathogenesis. Chronic lymphocytic leukemia (CLL) is the most
common B cell neoplasia and is characterized by the accumula-
tion of mature long-lived B cells in the blood and lymphoid tis-
sues and is due, at least in part, to an impairment of cytotoxic
immunity. While very efficient in presenting tumor-associated
antigens (Trojan et al., 2000), CLL B cells have been shown to
resist being killed by autologous CTLs (Krackhardt et al.,
2002). Here, we addressed the mechanisms of leukemic B cell
resistance by analyzing themolecular features of immune synap-
ses formed between effector CTLs and B cells that were freshly
isolated from CLL patients and healthy donors. We observed
that resting B cells, even from healthy donors, were intrinsically
resistant to cytotoxic lysis and that this was due to their ability
to induce dysfunctional degranulation in CTLs.RESULTS
Resting B Cells Resist Being Killed by Inducing Non-
Lytic Degranulation in Freshly Isolated Effector CTLs
Toacquire insight intomolecularmechanismsunderlying the func-
tional impairment of effector CTLs,we first assessed the cytotoxic
potential of CTLs freshly isolated from peripheral blood of CLL
patients who had never received any treatment. These patients
showed an elevated percentage of CD28 CD8+ CTLs belongingCell Reports 15, 9–18, April 5, 2016 ª2016 The Authors 9
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Effector CTLs fromUntreated CLL
Patients and Healthy Donors but Not CTL
Blasts or CTLs from Immunotherapy-
Treated Patients Fail to Lyse Donor B Cells
Despite Regular Degranulation
(A) Immunophenotypic analysis of CTLs isolated
from peripheral blood of CLL patients (n = 18) and
healthy donors (n = 18). Each dot represents a
single patient.
(B) Flow cytometry profile of the total CD8+ pop-
ulation from a CLL patient and a healthy donor.
(C) Flow cytometry analysis of cytotoxicity and
degranulation for CTLs freshly isolated from CLL
patients (n = 5) and healthy donors (n = 5).
(D) Flow cytometry analysis of cytotoxicity and
degranulation for freshly isolated CTLs and CTL
blasts expanded from the same donor by PHA/
IL-2 stimulation.
(E) Flow cytometry analysis of cytotoxicity and
degranulation for CTL blasts expanded from
healthy donors (n = 3) by CMV peptide/IL-2.
(F) Flow cytometry analysis of cytotoxicity and
degranulation for CTLs freshly isolated from
immunotherapy-treated CLL patients (n = 3).
For assays CTL blasts were incubated with indi-
cated targets at 1:1, 3:1, and 9:1 CTL-to-target
ratio for 4 hr. Shown are mean values ± SD; *p <
0.01, **p < 0.01, ***p < 0.001.to the effector perforin-rich subset (Figures 1A and 1B). CLLCTLs
appeared tomaintain functional competence given that theywere
able to kill control targets such as the CLL-derived B cell lineMEC
loadedwith superantigen (SAg) to promote polyclonal TCR recog-
nition (Figure1C; leftpanel).Cytotoxic lysisofMECcells correlated
with CTL degranulation that was assessed as surface transloca-
tion of the lysosome-associated membrane protein 1 (LAMP1)
that associates with the CTL surface during granule exocytosis
(Figure 1C; right panel) (Betts et al., 2003). By contrast, CTLs
showed greatly reduced levels of cytotoxicity when conjugated10 Cell Reports 15, 9–18, April 5, 2016with SAg-loaded autologous CLL B cells
while degranulating to a similar extent
(Figure 1C; Figure S1). Strikingly, CTLs
freshly isolated from healthy donors were
able to kill susceptible MEC targets, while
their cytotoxicity against autologous B
cells was inhibited despite regular degran-
ulation (Figure 1C). Hence, our findings
suggested that non-lytic degranulation of
freshly isolated CTLs could be induced
specifically in the presence of donor B
cells, irrespective of malignancy status.
The phenotype of CTLs can be altered
upon in vitro expansion in the presence
of interleukin-2 (IL-2) (Hackmann et al.,
2013; Zippelius et al., 2004). We there-
fore expanded CTLs in vitro by IL-2 and
phytohaemagglutinin (PHA) stimulation
and evaluated their cytotoxic potential
relative to freshly purified CTLs from
the same donor. Although we could notdirectly compare cytotoxicity of unstimulated CTLs and CTL
blasts as a result of differences in the percentage of perforin-
positive CTLs (average 23.0% ± 12.3% and 60.8% ± 9.2% in to-
tal pool, respectively), we could nonetheless compare how their
cytotoxic behavior changed in respect to different targets. At
variance with their freshly purified counterparts, expanded CTL
blasts acquired the potential to kill SAg-loaded donor B cells
(Figure 1D). Likewise, CMV-specific CTL blasts could kill donor
B cells pulsed with either SAg or CMV peptide (Figure 1E). In
addition, we observed that CTLs freshly isolated from patients
Figure 2. Non-Lytic Degranulation of CTLs
Is Associated with a Selective Perturbation
of Late CTL Polarization Events
(A) Immunofluorescence images of lytic and non-
lytic CTL synapses (40min) stainedwith antibodies
against perforin and exocytosed LAMP1 (exo-
LAMP1).
(B and C) Quantitative analysis of lytic granule
and exoLAMP1 polarization in perforin-positive
CTLs from CLL patients (n = 5) and healthy donors
(n = 4 or 5).
(D and E) Immunofluorescence images of (D) lytic
and (E) non-lytic CTLsynapses (30min) stainedwith
antibodies against PKCq, g-tubulin, and perforin.
(F) Analysis of PKCq/MTOC/lytic granule polariza-
tion in perforin-positive CTL synapses (n = 5–9
donors). Values are expressed as the percentage of
conjugates among total conjugates (left panel),
conjugates with polarized PKCq (middle panel), and
conjugates with a polarized MTOC (right panel).
(G) Analysis of granule polarization in synapses of
CTL blasts (n = 3 donors). Measurements were
taken from 30 conjugates for each donor and
condition; each dot represents mean value for a
single donor. Images are representative of 9 in-
dependent experiments. Scale bar, 5 mm. Shown
are mean values ± SD; **p < 0.01, ***p < 0.001.treated with a combination of B-cell-targeting antibodies and
chemotherapywere also able to kill autologousBcells (Figure 1F;
see the Supplemental Experimental Procedures for details on
therapy regimens). We associated this enhancement in cytotox-
icity with a phenotypical change occurring in CTLs, since the
same cells were also able to kill allogeneic B cells of healthy
donors (Figure 1F). Our findings therefore imply that an alteration
of the phenotype induced in CTLs by IL-2 activation in vitro
or immunotherapy in vivo dramatically enhances the ability of
CTLs to kill donor B cells.
B Cells Fail to Induce Polarized Degranulation of Lytic
Granules Directed to the IS
Imaging analysis of synapses formed by freshly isolated CTLs re-
vealed that, while MEC targets promoted the formation of lytic IS
with perforin-positive granules both polarized and exocytosed in
the direction of synaptic cleft, resistant B cell targets failed to
induce polarization of the granules despite inducing degranula-
tion (Figure 2A). Quantitative analysis confirmed that the majority
of effector CTLs from both CLL and healthy donors engagedwith
MEC targets were able to concentrate lytic granules at the IS and
release them locally, while they had a dramatically impaired abil-ity to translocate granules toward the IS
with B cells. (Figures 2B and 2C).
To evaluate whether a defect in granule
polarization could indeed be responsible
for inhibited CTL function, we assessed if
the Fas/FasL axis, a secondmajormecha-
nism of intrinsic CTL cytotoxicity (Trapani
and Smyth, 2002), was implicated in killing
by freshly isolatedCTLs.Weobserved that
neither FasL-blocking antibody nor CTL
pre-treatment with brefeldin, which blocks the exocytosis of
FasL-containing vesicles (Li et al., 1998), inhibited cytotoxicity
against MEC cells (Figures S2A and S2B). Additionally, in a panel
of B cell lines, we found that the Burkitt lymphoma-derived line
BJAB, resistant to being killed and able to induce non-polarized
CTL degranulation, exhibited similar levels of Fas expression
and sensitivity to anti-Fas-antibody-induced cell death as com-
pared to MEC cells (Figure S2C–S2G). This finding suggests that
in our system the Fas/FasL pathway contributes minimally to the
cytotoxic potential of freshly isolated CTLs.
We further compared different phases of IS maturation for lytic
and non-lytic IS and observed that, in CTLs conjugated with
MEC cells, PKCq accumulated at the IS leading toMTOCand lytic
granule polarization (Figure 2D). In CTLs conjugatedwith resistant
B cells, PKCq andMTOC translocated toward the IS normally, but
this did not lead to polarization of lytic granules (Figures 2E and
2F;left panel). Consistently, a similar difference ingranule polariza-
tion was observed for CTL conjugates with either PKCq or MTOC
already recruited to the synapse (Figure 2F, middle and right
panels). Importantly, the acquisition of cytotoxic potential against
donor B cells by in vitro expanded CTL blasts correlated with the
ability of CTLs to polarize their lytic granules at the IS (Figure 2G),Cell Reports 15, 9–18, April 5, 2016 11
Figure 3. Non-Lytic Degranulation Can Be Induced in Functional Lytic Synapses by Microtubule Disruption but Not by Lowering the Number
of Engaged TCRs or Withdrawal of LFA-1 Costimulation
(A and B) Quantitative analysis of MTOC/granule polarization in perforin-positive CTLs incubated for 30 min with MEC cells (A) pulsed with different SAg con-
centrations or (B) at different concentrations of blocking ICAM-1-specific antibody.
(C) Immunofluorescence images of synapses (40 min, stained for perforin and exo-LAMP1) between MEC cells and CTLs pre-treated with 80 mM colchicine or
carrier for 30 min prior to conjugation. Scale bar, 5 mm.
(D and E) Flow cytometry analysis of degranulation (D) and cytotoxicity (E) on control and colchicine-treated CTLs incubated with MEC targets for 4 hr.
Quantitative analysis of lytic granule and exoLAMP1 polarization in control and colchicine-treated perforin-positive CTLs incubated with MEC cells for 40 min
(30 conjugates per donor and condition) is shown (E).
Each dot represents mean values for three donors (A and B) or a single donor (D–F). Shown are mean values ± SD; *p < 0.05, ***p < 0.001.thus suggesting that the observed differences in killing cytotoxic
potential were primarily defined by CTL ability to control granule
movement.
Finally, we analyzed F-actin polarization in CTLs engaged with
B cells and MEC targets, as it has been proposed that CLL CD4+
and CD8+ T cells have an intrinsic defect in actin polymerization
at the IS (Ramsay et al., 2008). Our analysis indicated that non-
lytic synapses had a decreased capacity to polymerize actin at
the IS (Figures S3A and S3B). This finding therefore suggests
that an impaired F-actin accumulation at the IS could be poten-
tially linked to a selective defect in late polarization events char-
acteristic of non-lytic CTL synapses.
Non-Lytic CTL Degranulation Does Not Depend on the
Number of Engaged TCRs or LFA Costimulation
TCR triggering with low-affinity ligands can lead to an impairment
in lytic granule polarization and exocytosis (Jenkins et al., 2009),12 Cell Reports 15, 9–18, April 5, 2016thus potentially implicating the strength of TCR triggering in the
control of granulemovement. Considering that we used amixture
of SAgs for target cell pulsing, the affinity of TCR binding to HLA-
DR/SAg complexes displayed byMECand B cells was compara-
ble, although it could be argued that the defect inCTLpolarization
occurred as a result of different numbers of TCRs engaged
(average mean fluorescence intensity [MFI] HLA-DR 279.7 ±
50.5 forMECand 107.2± 25.5 for B cells). To test this hypothesis,
we pulsed MEC cells with progressively lower concentrations of
the SAg mixture and observed that decreasing HLA-DR/SAg led
to a decline in the number of CTL conjugates able to polarize
MTOC and perforin granules. However, the granules did not fail
to follow the MTOC at any SAg concentration (Figure 3A). Hence,
factors other than the number of engaged TCRs are likely to be
responsible for the inhibition of granule polarization in non-lytic IS.
Lymphocyte function-associated antigen-1 (LFA-1) interac-
tion with intracellular adhesion molecule (ICAM-1) expressed
on antigen-presenting cells (APCs) has been shown to facilitate
CTL killing by stabilizing the nascent IS (Anikeeva et al., 2005).
We observed that, although donor B cells expressed less
ICAM-1 compared to MEC cells, the resistant BJAB cells had
comparably high ICAM-1 levels (Figure S3C), suggesting that
an enhanced LFA-1 costimulation was not sufficient to promote
lytic granule polarization. Moreover, the relatively lower ICAM-1
levels on donor B cells were nonetheless sufficient to promote
significant LFA-1 accumulation at the IS (Figures S3D and
S3E), concomitant with recruitment of phosphorylated Vav-1
and talin, which are typically activated following LFA-1 triggering
(Figures S3F–S3H) (Nolz et al., 2007). Additionally, an ICAM-1
blockade affected the efficiency of CTL conjugation as expected
but did not provoke uncoupling between the MTOC and granule
movement in synapses that were still formed (Figure 3B). Taken
together, all three lines of evidence indicated that a decreased
LFA-1 polarization in non-lytic synapses was not responsible
for defective granule polarization.
Non-Lytic Degranulation Can Be Induced in Functional
Lytic Synapses by Microtubule Disruption
To evaluate whether interference with granule translocation
could lead to a non-lytic CTL degranulation, we analyzed synap-
ses of CTLs pre-treated with the microtubule-disrupting agent
colchicine. Interestingly, although the treatment induced a
complete collapse of the microtubule cytoskeleton, colchicine-
treated CTLs were still able to degranulate when engaged with
MEC cells (Figures 3C and 3D). Cytotoxicity of such CTLs
decreased significantly (Figure 3E), which correlated with
randomization in their degranulation pattern (Figure 3F). This
finding indicated that non-polarized granule exocytosis could
be one of the principal factors responsible for CTL dysfunction.
Non-Lytic Degranulation of Freshly Isolated CTLs Is
Associated with a Selective Defect in LAT Activation
The strength of TCR-induced signaling and kinetics of Ca2+ influx
could have an important and non-redundant function in the regu-
lation of lytic granule polarization (Beal et al., 2009; Jenkins et al.,
2009). In view of this, we evaluated both parameters in freshly
isolated enriched CTL effectors (Figure S4) and CTL blasts
engaged with either MEC or donor B cells. Thus, we explored
one case of non-lytic (unstimulated effector CTLs + B cells)
and three cases of lytic (unstimulated effector CTLs + MEC cells
and CTL blasts + B cells/MEC cells) degranulation. We did not
observe significant differences in the overall profile of Ca2+
elevation between the different combinations, although Ca2+
influx was significantly accelerated in CTL blasts (60.0 ± 4.0 s
after CTL-target contact to influx) compared to freshly isolated
CTLs (176.3 ± 18.2 s) (Figure 4A). Therefore, at variance with
the altered granule polarization in CD4+ CTL blasts associated
with diminished Ca2+ influx (Beal et al., 2009), no obvious defect
in Ca2+ signaling characterized non-lytic CTL degranulation.
Assessing the strength of TCR-induced signaling in the same
experimental setup showed that the magnitude of ZAP-70 and
Erk2 phosphorylation were similar between non-lytic and lytic
synapses, while activation of the linker for activation of T cells
(LAT) and extracellular-signal-regulated kinase 1 (Erk1) were
significantly decreased in freshly isolated effector CTLs engagedwith resistant B cell targets (Figures 4B and 4C). However, treat-
ment of CTLs with the Erk inhibitor PD98059 did not affect either
granule polarization or cytotoxic potential of freshly isolatedCTLs
(FiguresS5AandS5B), rulingout adefectiveErk1activation in the
non-lytic degranulation phenotype. Furthermore, protein kinase
Akt was activated in CTLs engaged with MEC cells but became
poorly activated in B cell synapses with both unstimulated
CTLs and CTL blasts (Figures 4B and 4C). Considering that
CTL blasts showed strong cytotoxicity against B cells (Figures
1D and 1E) and that the Akt inhibitor wortmannin did not affect
granule polarization in CTL synapses (Figure S5C), our data indi-
cated that Akt signaling is dispensable for cytotoxic killing.
Finally, using imaging analysis of protein phosphorylation at
the IS we confirmed that ZAP-70 was equally activated in both
lytic and non-lytic synapses, while LAT activation was selectively
blocked in the latter case (Figures 4D and 4E). Therefore, our
findings provide evidence that non-lytic degranulation of freshly
isolated CTLs is associated with a defect in LAT activation, but
not Akt or Erk1 signaling, and that the acquisition of killing capac-
ity by CTL blasts is accompanied by intact LAT signaling.
Both Lytic and Non-Lytic Degranulation Is Dependent on
a Rab7/Rab27a-Positive Compartment
Rab27a, a member of the Rab subfamily of GTPases, which is
dispensable for lytic granule transport to the IS, defines a late en-
dosomal compartment that promotes lytic granule maturation
and exocytosis (Me´nager et al., 2007). Confocal imaging of
Rab27a in freshly isolated CTLs showed that the Rab27a-posi-
tive compartment extensively colocalized with another late en-
dosomal marker, Rab7 (Figure 5A). However, neither Rab27a
nor Rab7 showed a significant colocalization with lytic granules
as compared to the granule marker LAMP1 (Figure 5B–5D),
although occasional fusion events could be detected between
Rab27a/Rab7 and lytic granules in CTLs engaged in synapses
(Figure 5B and 5C). Rab27a depletion by siRNA nucleofection
led to a dramatic impairment in the ability of freshly isolated
CTLs to degranulate with both MEC and B cells (Figure 5E and
5F) thus indicating that Rab27a, together with Rab7, defines a
vesicular compartment which is essential for both lytic and
non-lytic degranulation of CTLs.
The Arl8 Adaptor Is Necessary for Microtubule-Based
Migration of Lytic Granules and Degranulation
The ADP-ribosylation factor-like protein 8 (Arl8), identified in the
lysosomal proteome, has been implicated in kinesin-dependent
plus-end directed granule movement toward the cell periphery
(Nylandsted et al., 2011; Rosa-Ferreira and Munro, 2011). We
analyzed its possible implication in lytic granule movement in
CTLs and observed that Arl8-specific staining largely overlapped
with perforin-positive granules in resting CTLs (Figure 5D–5G).
Importantly, it also colocalized with lytic granules in CTLs
engaged in synapses (Figure 5G), suggesting that kinesin-bind-
ing Arl8 could be implicated in lytic granule transport.
Of the two Arl8 isoforms, Arl8a and Arl8b, which are 91% iden-
tical and phenocopy each other, the latter seemed to be the pre-
dominant isoform expressed in CTLs, similar to dendritic and NK
cells (Garg et al., 2011; Tuli et al., 2013) (Figure 5H). Consistent
with the high sequence homology between the two genes, weCell Reports 15, 9–18, April 5, 2016 13
Figure 4. Non-Lytic Degranulation of Freshly Isolated CTLs Is Associated with a Selective Defect in LAT Activation which Is Rescued in
In Vitro Expanded CTL Blasts
(A) Time-dependent changes in intracellular Ca2+ concentration in freshly isolated CTLs and CTL blasts induced by interaction with targets (n = 2 donors). The
curves represent mean values ± SD for 20 CTLs.
(B) Immunoblots of non-lytic and lytic CTL synapses. *Non-specific bands.
(C) Quantification of immunoblots (n = 2 or 3 donors).
(D and E) Immunofluorescence images (D) and quantitative analysis (E) of ZAP-70/LAT phosphorylation in perforin-positive CTL synapses. Values are expressed
as a difference in average fluorescence intensity of two synaptic membrane regions versus two distal membrane regions; 20 conjugates were analyzed for each
donor (n = 2) and condition.
Immunoblots and images are representative of three and two independent experiments for freshly isolated CTLs and CTL blasts, respectively. Scale bar, 5 mm.
Shown are mean values ± SD; *p < 0.05, **p < 0.01, ***p < 0.001.
14 Cell Reports 15, 9–18, April 5, 2016
Figure 5. Non-Lytic Degranulation Is Dependent on a Rab7/Rab27a-Positive Compartment and Arl8-Assisted Lytic Granule Translocation
(A) Immunofluorescence images and colocalization analysis of Rab7/Rab27-positive compartments in freshly isolated CTLs.
(B and C) Immunofluorescence images of CTLs, either as such or conjugated with targets for 40 min, stained with antibodies against perforin and Rab27a/Rab7
(n = 3 donors).
(D) Co-localization analysis between lytic granules, LAMP1-, Rab27a-, Rab7- and Arl8-positive compartments in CTLs. Quantitative measurements were taken
for 15-20 CTLs (n = 2 donors).
(E) Flow cytometry analysis of degranulation on pmaxGFP/siRNA co-trasfected CTLs analyzed at 40/70 hr post-nucleofection for B cell/MEC conjugates,
respectively.
(legend continued on next page)
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were only able to assess the impact of global Arl8 silencing in our
system since the Arl8b-specific siRNA pool knocked down both
Arl8a and Arl8b (Figure 5H). First, Arl8 depletion resulted in the
perinuclear clustering of lytic granules (Figure 5I), suggesting
that Arl8 favors lytic granule positioning in the proximity of the
plasmamembrane. Furthermore, Arl8 silencing led to a profound
impairment in the ability of CTLs to degranulate both with donor
B cells and MEC cells (Figure 5J), while the effect of siRNA treat-
ment was reversed by co-transfecting CTLs with a vector-ex-
pressing Arl8b (Figure 5K and 5L). Given that it has been
observed that Arl8b silencing negatively affects MTOC recruit-
ment at the synapse in NK cells (Tuli et al., 2013), we analyzed
MTOC polarization in Arl8-silenced CTLs. We did not observe
a decrease in MTOC translocation toward the IS (Figure 5M),
indicating that the phenotype of Arl8 deficiency was associated
with inhibited granule movement but not MTOC migration.
Collectively, our observations indicate that Arl8 is essential for
both non-lytic and lytic degranulation of CTLs.
DISCUSSION
Here, we illustrate a peculiarity of the interaction between resting
human B cells and effector CTLs, resulting in a dysfunctional
degranulation and unexpectedly shared by both leukemic and
healthy cells. We found that B cells, which are intrinsically
susceptible to cytotoxic lysis can instruct CTLs to release lytic
granules in a non-polarized fashion and thus protect themselves
from being killed. This may be relevant in the context of B cell
malignancies. We attempted to dissect the underlying molecular
mechanism and found that an impaired convergence of
lytic granules toward the IS was associated with a selective
blockade of the TCR-signaling cascade at the level of LAT.
This impaired convergence was achieved through Arl8-assisted
lytic granule movement toward the cell periphery where the
granules mature by fusing with Rab27a- andRab7-positive late
endosomes and release their contents diffusely rather than into
the synaptic cleft.
The phenotype of non-lytic degranulation, in which ZAP-70
activation and Ca2+ influx proceed without further spread of
the signaling onto LAT, contrasts with a situation in which
engagement of murine CTL blasts with low-affinity ligands
causes a dramatic defect in the activation of lymphocyte-spe-
cific protein tyrosine kinase (Lck) thus leading to a profound
block in both lytic granule polarization and degranulation (Jen-
kins et al., 2009). Coupled with this observation, our results imply
an important bifurcation of TCR signaling in CTLs. We propose
that the signaling upstream of ZAP-70 controls CTL activation(F) Immunoblots of CTLs nucleofected with siRNAs and analyzed at 40/70 hr pos
(G) Images of CTLs (n = 5 donors), either as such or conjugated with targets for
(H) Immunoblots of CTLs nucleofected with siRNAs (left); quantification of n = 3
(I) Images of CTLs nucleofected with siRNA (n = 3 donors) stained with antibodie
(J) Flow cytometry analysis of degranulation on pmaxGFP/siRNA co-trasfected C
respectively.
(K and L) Rescue experiment was performed by co-transfecting CTLs (n = 2 do
quantification and (L) flow cytometry analysis of degranulation on 40 hr post-tre
represents the replicate value for a single donor (n = 3 or 4).
(M) Quantitative analysis of MTOC polarization in synapses (30 per donor, n = 3) of
nucleofection for B cell and MEC conjugates, respectively. Scale bar, 5 mm; sho
16 Cell Reports 15, 9–18, April 5, 2016generally while signaling downstream of ZAP-70, as exemplified
here by LAT, finely tunes the pattern of CTL polarization.
We demonstrate that LAT signaling is intact in CTL blasts,
which are cytotoxic to otherwise resistant B cells. Our observa-
tion might also explain why non-lytic degranulation could have
been overlooked in the traditional experimental setups based
on the usage of CTL blasts. In vitro expansion boosts effector
functions of tumor-specific CTLs that are isolated from mela-
noma patients (Zippelius et al., 2004) and can even restore
cytotoxicity in CTLs and NK cells from patients with genetic
mutations (Bryceson et al., 2007; Hackmann et al., 2013). In
this regard, it is interesting to note, according to our data, a
similar phenotypical change occurs in CTLs from leukemic pa-
tients in response to a combined chemo-immunotherapy treat-
ment. Collectively, our work underscores the importance of
studying freshly isolated CTLs and the function of LAT that could
provide important insights into the mechanisms regulating lytic
granule transport.
Our results identify the kinesin-binding Arl8 as one of the fac-
tors controlling lytic granule positioning. Importantly, while Arl8
appears to promote the plus-end directed movement of lytic
granules during non-lytic degranulation, it might also play a
role in the assembly of a conventional lytic synapse of CTLs. In
support of our findings, it has been demonstrated that the
terminal transport of granules toward the synaptic interface is
kinesin-1-dependent (Kurowska et al., 2012), thus potentially
implicating Arl8 in this process.
We also show that lytic granule maturation mediated by
Rab27a is implicated in non-lytic degranulation of CTLs. Rab7,
which extensively colocalized with the Rab27-positive compart-
ment, has already been implicated in regulation of lytic granule
polarization based on the observation that an overexpression
of the dynein-binding effector of Rab7 and RILP in human CTL
blasts has been shown to promote granule translocation in the
minus-end direction and clustering around the MTOC (Daniele
et al., 2011; Stinchcombe et al., 2006). We and others, however,
failed to detect an association between Rab7 and lytic granules
by immunofluorescence analysis (Me´nager et al., 2007), which
implies that the identity of trafficking regulators for lytic granules
is yet to be confirmed.
Further studies are needed to understand if the mechanism of
non-lytic CTL degranulation might play a role in tumor growth
and could represent a mechanism of immune evasion. Interest-
ingly, though, our findings underscore the role of B cells in
immune regulation of cytotoxic response since B cells have
long been suggested to play a role in the induction of tolerance
in naive CD8+ T cells (Bennett et al., 1998; Overstreet et al.,t-treatment (left); quantification of n = 3 immunoblots (right).
40 min and stained with antibodies against perforin and Arl8.
immunoblots (right).
s against perforin and Arl8.
TLs analyzed at 40/70 hr post-nucleofection for B cell and MEC conjugates,
nors) with siRNAs and Arl8b-pmax vectors. Shown are (K) immunoblots with
atment CTLs engaged with donor B cells. In graphs (E), (J), and (L), each dot
GFP-positive CTLs co-transfected with pmaxGFP/siRNA at 40 and 70 hr post-
wn are mean values ± SD; *p < 0.05, **p < 0.01, ***p < 0.001.
2010; Qin et al., 1998). In turn, our work illustrates a molecular
mechanism by which antigen-presenting B cells can directly
affect functioning of effector CTLs. In this regard, major
questions that are still unanswered include which stimuli are
responsible for the induction of non-lytic degranulation and
what impact this regulatory process may have on tumor patho-
genicity in vivo.
EXPERIMENTAL PROCEDURES
Patients and Healthy Controls
Peripheral blood samples of CLL patients (18 untreated and three treated as
indicated in the Supplemental Experimental Procedures) and healthy donors
were analyzed after we received their signed informed consent according to
institutional guidelines.
Lymphocyte Isolation and Culture
CTLs and B cells were purified by negative selection using RosetteSep cock-
tails (StemCell) to purity > 95% for CTLs and >90% for B cells. Primary lympho-
cytes were cultured in bicarbonate-free RPMI-1640 with 20 mM HEPES
(RPMI-HEPES), 7.5% iron-enriched HyClone BCS (ThermoScientific), and
2 mM L-glutamine and 50 IU/mL penicillin. For the assays with freshly isolated
CTLs, we chose donors with at least 15%of perforin-positive cells among total
CD8+ population (average 23.0% ± 12.3%).
Culturing of B cell lines, reagents, generation of CTL blasts and colchicine
treatment of CTLs, flow cytometry assays of cytotoxicity and CTL degranula-
tion, Ca2+ flux measurements, and antibodies used for flow cytometry are
detailed in the Supplemental Experimental Procedures and Table S1.
Immunofluorescence Microscopy
APCs (1.25 3 105) were loaded with SAg mixture and 2.5 mM Cell-Tracker-
Blue (Invitrogen), then washed in RPMI-HEPES and incubated with CTLs
(1.25 3 105) in 20 ml of RPMI-HEPES at 37C bath for the indicated time.
15 min before the end of conjugation cells were gently re-suspended and
transferred onto slides- then fixed with 4% formaldehyde and stained as
indicated in Table S2. Confocal microscopy on 0.9-mm-thick sections was
performed on a LSM700 (CarlZeiss) using a 633 objective with Zen-2009
software and processed with ImageJ. For the quantitative analysis CTL con-
jugates were scored as having polarized granules/exo-LAMP1 vesicles if the
large majority (>90%) of granules/vesicles were localized at the IS. Colocal-
ization analysis was performed by calculating Manders coefficient with the
JACoP plugin.
Immunoblotting
Equal amount of cell lysates (10–20 mg of lysates for phospho-blotting
prepared as indicated in the Supplemental Experimental Procedures or 106
cells for Rab27/Arl8 blotting) were immunoblotted using primary antibodies
(Table S3).
CTL Nucleofection with siRNAs
Freshly isolated CTLs (5–10 3 106) were nucleofected with 200 nM iBONi
siRNA pools (Table S4; Riboxx GmbH) and 2 mg pmax-GFP vector using a
Human T Cell Nucleofector kit (Lonza, program V-024). siRNA rescue experi-
ment is detailed in the Supplemental Experimental Procedures.
Statistics
Mean values, SD values, and the p values associated with two-tailed unpaired
Student’s test were calculated using the GraphPad software.
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